Hemab Therapeutics logo

Hemab Therapeutics Employee Directory

Biotechnology ResearchHovedstaden, Denmark51-200 Employees

Hemab Therapeutics is a clinical-stage biotechnology company focused on preventive therapies for serious, underserved bleeding and thrombotic disorders. It advances monoclonal and bispecific antibody-based candidates designed to prevent bleeding events or thrombotic complications in patients with high unmet medical needs, including conditions such as Glanzmann thrombasthenia, factor VII deficiency, Bernard-Soulier syndrome, and von Willebrand disease. The company operates from Cambridge, Massachusetts and Copenhagen, Denmark, and has outlined a plan to advance five clinical assets by 2025 under its Hemab 1-2-5 strategy. This positions Hemab within the biotechnology research sector as a developer focused on prophylactic biologics for rare clotting disorders. In 2025, Hemab appointed Anant Murthy as Chief Operating Officer, reflecting organizational growth alongside its clinical development efforts.

Find Hemab Therapeutics employees' phone numbers or email addresses

Hemab Therapeutics Global Highlights

Location
Employees

Europe
51

Minus sign iconPlus sign icon
  • Denmark
    41
  • Sweden
    3
  • United Kingdom Of Great Britain And Northern Ireland
    2
  • Austria
    1
  • France
    1
  • Poland
    1
  • Italy
    1
  • Switzerland
    1

North America
37

Minus sign iconPlus sign icon
  • United States Of America
    36
  • Canada
    1

Asia
1

Minus sign iconPlus sign icon
  • United Arab Emirates
    1

Hemab Therapeutics's Leadership

  • Chief Operating Officer at Hemab Therapeutics
    A. M.
    Chief Operating Officer
  • Chief Financial Officer at Hemab Therapeutics
    M. B.
    Chief Financial Officer
  • Vice President Finance at Hemab Therapeutics
    K. K. J.
    Vice President Finance
  • Vice President Drug Product Development at Hemab Therapeutics
    A. R. H. S.
    Vice President Drug Product Development
  • Vice President Regulatory Affairs at Hemab Therapeutics
    E. B.
    Vice President Regulatory Affairs
  • Vice President Clinical Research at Hemab Therapeutics
    C. R.
    Vice President Clinical Research
  • Scientific Vice President at Hemab Therapeutics
    H. Ø.
    Scientific Vice President
  • Svp, Cmc And Manufacturing at Hemab Therapeutics
    C. B.
    Svp, Cmc And Manufacturing

Hemab Therapeutics Employee Metrics

100%
50%
0%
2026
2025
  • Biotechnology
  • Business
  • Entrepreneurship
  • Sales
  • Human Resources
  • Other
  • Legal
  • Accounting

Contact profiles from Hemab Therapeutics

Name
Title
Contact
Location
Last Update
  • Chief Operating Officer at Hemab Therapeutics
    A. M.
    Chief Operating Officer
    Switzerland
    Sep 03, 2026
  • Chief Financial Officer at Hemab Therapeutics
    M. B.
    Chief Financial Officer
    Denmark, Capital Region
    Aug 28, 2026
  • Vice President Finance at Hemab Therapeutics
    K. K. J.
    Vice President Finance
    Denmark, Capital Region
    Sep 08, 2026
  • Scientific Vice President at Hemab Therapeutics
    H. Ø.
    Scientific Vice President
    Denmark
    Jun 26, 2026
  • Svp, Cmc And Manufacturing at Hemab Therapeutics
    C. B.
    Svp, Cmc And Manufacturing
    France, Paris
    Sep 08, 2026
  • Vp, Research at Hemab Therapeutics
    T. B.
    Vp, Research
    Denmark
    Sep 08, 2026
  • Vice President Drug Product Development at Hemab Therapeutics
    A. R. H. S.
    Vice President Drug Product Development
    Denmark, Capital Region
    Sep 06, 2026
  • Vice President, Nonclinical Development at Hemab Therapeutics
    C. E. R.
    Vice President, Nonclinical Development
    Denmark
    Jun 30, 2026
  • Vice President Regulatory Affairs at Hemab Therapeutics
    E. B.
    Vice President Regulatory Affairs
    Switzerland, Zurich
    Aug 06, 2026
  • Vice President Clinical Research at Hemab Therapeutics
    C. R.
    Vice President Clinical Research
    United Kingdom, United Kingdom
    Aug 25, 2026

Frequently Asked Questions

What is Hemab Therapeutics known for?

Minus sign iconPlus sign icon
Hemab Therapeutics was founded in 2020 and operates in the Biotechnology Research industry. Explore Hemab Therapeutics's company overview page for more information.

What is Hemab Therapeutics's most common email format?

Minus sign iconPlus sign icon
Hemab Therapeutics employees' email format typically follows the pattern of First@hemab.com. Trying to find reliable and up-to-date employee contact data? Find more Hemab Therapeutics email formats with LeadIQ.

How many employees does Hemab Therapeutics have currently?

Minus sign iconPlus sign icon
Hemab Therapeutics has approximately 91 employees as of August 2026. These team members are located across 3 continents, including Europe, North America and Asia.

Who are Hemab Therapeutics's key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, Hemab Therapeutics's key employees include:

  • Chief Operating Officer: A. M.
  • Chief Financial Officer: M. B.
  • Vice President Finance: K. K. J.
  • Vice President Drug Product Development: A. R. H. S.
  • Vice President Regulatory Affairs: E. B.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.